These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 25984993)
1. DNA vaccines, electroporation and their applications in cancer treatment. Lee SH; Danishmalik SN; Sin JI Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993 [TBL] [Abstract][Full Text] [Related]
2. DNA vaccine for cancer immunotherapy. Yang B; Jeang J; Yang A; Wu TC; Hung CF Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927 [TBL] [Abstract][Full Text] [Related]
3. Antigen-specific vaccines for cancer treatment. Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639 [TBL] [Abstract][Full Text] [Related]
4. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic gene modified cell based cancer vaccines. Kozłowska A; Mackiewicz J; Mackiewicz A Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846 [TBL] [Abstract][Full Text] [Related]
6. Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control. Lee IH; Park JB; Cheong M; Choi YS; Park D; Sin JI DNA Cell Biol; 2011 Dec; 30(12):975-85. PubMed ID: 21649506 [TBL] [Abstract][Full Text] [Related]
7. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933 [TBL] [Abstract][Full Text] [Related]
9. NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses. Ligtenberg MA; Rojas-Colonelli N; Kiessling R; Lladser A Hum Vaccin Immunother; 2013 Oct; 9(10):2189-95. PubMed ID: 23884215 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of PSA and PSMA DNA vaccines with electroporation induces potent immune responses. Ferraro B; Cisper NJ; Talbott KT; Philipson-Weiner L; Lucke CE; Khan AS; Sardesai NY; Weiner DB Hum Vaccin; 2011; 7 Suppl():120-7. PubMed ID: 21266849 [TBL] [Abstract][Full Text] [Related]
11. Cancer vaccination by electro-gene-transfer. Aurisicchio L; Mancini R; Ciliberto G Expert Rev Vaccines; 2013 Oct; 12(10):1127-37. PubMed ID: 24066796 [TBL] [Abstract][Full Text] [Related]
12. A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination. Gálvez-Cancino F; Roco J; Rojas-Colonelli N; Flores C; Murgas P; Cruz-Gómez S; Oyarce C; Varas-Godoy M; Sauma D; Lladser A Vaccine; 2017 Jul; 35(33):4148-4154. PubMed ID: 28666759 [TBL] [Abstract][Full Text] [Related]
13. In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8 Sales NS; Silva JR; Aps LRMM; Silva MO; Porchia BFMM; Ferreira LCS; Diniz MO Vaccine; 2017 Dec; 35(52):7240-7249. PubMed ID: 29174677 [TBL] [Abstract][Full Text] [Related]
14. Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor. Lamolinara A; Stramucci L; Hysi A; Iezzi M; Marchini C; Mariotti M; Amici A; Curcio C J Immunol Res; 2015; 2015():159145. PubMed ID: 26247038 [TBL] [Abstract][Full Text] [Related]
15. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model. Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758 [TBL] [Abstract][Full Text] [Related]
16. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model. Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605 [TBL] [Abstract][Full Text] [Related]
17. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model. Ahn E; Kim H; Han KT; Sin JI Cancer Lett; 2015 Jan; 356(2 Pt B):676-85. PubMed ID: 25449428 [TBL] [Abstract][Full Text] [Related]
18. The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA. Ohlschläger P; Spies E; Alvarez G; Quetting M; Groettrup M Int J Cancer; 2011 Jan; 128(2):473-81. PubMed ID: 20309939 [TBL] [Abstract][Full Text] [Related]
19. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma. Lladser A; Ljungberg K; Tufvesson H; Tazzari M; Roos AK; Quest AF; Kiessling R Cancer Immunol Immunother; 2010 Jan; 59(1):81-92. PubMed ID: 19526360 [TBL] [Abstract][Full Text] [Related]
20. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models. Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]